Ziyu Qi

This study shows that Losartan, an angiotensin II type 1 receptor antagonist, alters social reward and punishment processing by modulating midbrain-striato-frontal circuits in humans.

This study uses a precision pharmacological fMRI approach to show that losartan reduces neural reactivity to fear-inducing stimuli by targeting AT1R, without affecting threat or novelty responses.

This study shows that different VBM processing pipelines produce highly variable brain maps, affecting region identification and interpretation of sex and age differences.

The paper uses fMRI and machine learning to identify a distributed neural signature predictive of subjective fear across multiple cohorts, showing it differs from other negative affect states.